Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:20 PM
Ignite Modification Date:
2025-12-24 @ 2:20 PM
NCT ID:
NCT02107495
Eligibility Criteria:
Inclusion Criteria:
* CHF Subjects: 21 years of age or greater, with clinically confirmed CHF or have presented to the clinical site with signs, symptoms and/or risk factors suggestive of heart failure.
* Subjects with Potentially confounding comorbidities: Non-CHF subjects 21 years of age or greater, with potentially confounding comorbidities such as diabetes, renal insufficiency, hypertension and chronic obstructive pulmonary disease (COPD)
* Healthy Subjects: apparently healthy subjects greater than 45 years of age, with no prior history of cardiac-related disease.
Exclusion Criteria:
* Apparently healthy subjects with a history of MI, CHF or other cardiac-related disease;
* Subjects with acute decompensated heart failure currently on nesiritide therapy;
* Subjects having participated in another experimental drug, biologic, or invasive device study within 30 days prior to signing informed consent for this study, or enrolled concurrently in any other investigative study; and
* Subjects unable to or refusing to provide written informed consent.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT02107495
Study Brief:
Protocol Section:
NCT02107495